Evidence map›Paper›PMID 41287757›Full record

ArticleRegenerative biomaterials2025

Ascorbic acid 2-phosphate-releasing poly-l-lactide-co-epsilon-caprolactone membranes enhance tissue regeneration: first

Alma Kurki, Markus Hannula, Susanna Miettinen, Henriikka Teittinen, Kaarlo Paakinaho, Jari Hyttinen, Jere Lindén, Reetta Sartoneva

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Regenerative biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Application of PLCL as a biodegradable polymer in biomedical engineering.Journal of materials science. Materials in medicine · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Alma KurkiFaculty of Medicine and Health Technology (MET), Tampere University, Tampere 33520, Finland.ORCID https://orcid.org/0000-0001-7978-6293
Markus HannulaFaculty of Medicine and Health Technology (MET), Tampere University, Tampere 33520, Finland.
Susanna MiettinenFaculty of Medicine and Health Technology (MET), Tampere University, Tampere 33520, Finland.
Henriikka TeittinenBiomendex Oy, Tampere 33720, Finland.
Kaarlo PaakinahoFaculty of Medicine and Health Technology (MET), Tampere University, Tampere 33520, Finland.
Jari HyttinenFaculty of Medicine and Health Technology (MET), Tampere University, Tampere 33520, Finland.
Jere LindénFaculty of Veterinary Medicine, Department of Veterinary Biosciences and Finnish Centre for Laboratory Animal Pathology, HiLIFE, University of Helsinki, Helsinki 00790, Finland.
Reetta SartonevaFaculty of Medicine and Health Technology (MET), Tampere University, Tampere 33520, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pelvic organ prolapse (POP) significantly impacts women's health and quality of life. There is a critical need for alternative biomaterials for surgical POP repair, driven by complications associated with conventional non-absorbable vaginal meshes. As ascorbic acid 2-phosphate (A2P) has been demonstrated to enhance collagen production and cell proliferation

Indexed as

ascorbic acid 2-phosphatecollagenin vivopelvic organ prolapsepoly-l-lactide-co-epsilon-caprolactone

Identifiers

PMID41287757
PMCPMC12640511

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.